Literature DB >> 20411407

Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes.

Qiong Zhou1, Zhijie Zheng, Bijun Xia, Lan Tang, Chang Lv, Wei Liu, Zhongqiu Liu, Ming Hu.   

Abstract

PURPOSES: Glucuronidation via UDP-glucuronosyltransferases (or UGTs) is a major metabolic pathway. The purposes of this study are to determine the UGT-isoform-specific metabolic fingerprint (or GSMF) of wogonin and oroxylin A, and to use isoform-specific metabolism rates and kinetics to determine and describe their glucuronidation behaviors in tissue microsomes.
METHODS: In vitro glucuronidation rates and profiles were measured using expressed UGTs and human intestinal and liver microsomes.
RESULTS: GSMF experiments indicated that both flavonoids were metabolized mainly by UGT1As, with major contributions from UGT1A3 and UGT1A7-1A10. Isoform-specific metabolism showed that kinetic profiles obtained using expressed UGT1A3 and UGT1A7-1A10 could fit to known kinetic models. Glucuronidation of both flavonoids in human intestinal and liver microsomes followed simple Michaelis-Menten kinetics. A comparison of the kinetic parameters and profiles suggests that UGT1A9 is likely the main isoform responsible for liver metabolism. In contrast, a combination of UGT1As with a major contribution from UGT1A10 contributed to their intestinal metabolism. Correlation studies clearly showed that UGT isoform-specific metabolism could describe their metabolism rates and profiles in human liver and intestinal microsomes.
CONCLUSION: GSMF and isoform-specific metabolism profiles can determine and describe glucuronidation rates and profiles in human tissue microsomes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411407      PMCID: PMC2897949          DOI: 10.1007/s11095-010-0148-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  34 in total

Review 1.  Atypical kinetic profiles in drug metabolism reactions.

Authors:  J Matthew Hutzler; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2002-04       Impact factor: 3.922

2.  Determination of wogonin in rat plasma by liquid chromatography and its pharmacokinetic application.

Authors:  T H Tsai; C J Chou; T R Tsai; C F Chen
Journal:  Planta Med       Date:  1996-06       Impact factor: 3.352

Review 3.  In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model.

Authors:  J B Houston; K E Kenworthy
Journal:  Drug Metab Dispos       Date:  2000-03       Impact factor: 3.922

4.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.

Authors:  Leslie E Carlini; Neal J Meropol; John Bever; Michael L Andria; Todd Hill; Philip Gold; Andre Rogatko; Hao Wang; Rebecca L Blanchard
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

6.  Involvement of p53 in oroxylin A-induced apoptosis in cancer cells.

Authors:  Rong Mu; Qi Qi; Hongyan Gu; Jia Wang; Yong Yang; Jingjing Rong; Wei Liu; Na Lu; Qidong You; Qinglong Guo
Journal:  Mol Carcinog       Date:  2009-12       Impact factor: 4.784

7.  The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase.

Authors:  H Yano; A Mizoguchi; K Fukuda; M Haramaki; S Ogasawara; S Momosaki; M Kojiro
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

8.  Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis.

Authors:  David Y Zhang; Josephine Wu; Fei Ye; Li Xue; Shiquan Jiang; Jizu Yi; Wandi Zhang; Huachen Wei; Max Sung; Wayne Wang; Xiaoping Li
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

9.  Quantitation of the flavonoid wogonin and its major metabolite wogonin-7 beta-D-glucuronide in rat plasma by liquid chromatography-tandem mass spectrometry.

Authors:  Xiaoyan Chen; Hongyan Wang; Yue Du; Dafang Zhong
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-08-05       Impact factor: 3.205

10.  Urinary pharmacokinetics of baicalein, wogonin and their glycosides after oral administration of Scutellariae Radix in humans.

Authors:  Miao-Ying Lai; Su-Lan Hsiu; Chung-Chuan Chen; Yu-Chi Hou; Pei-Dawn Lee Chao
Journal:  Biol Pharm Bull       Date:  2003-01       Impact factor: 2.233

View more
  15 in total

1.  Sulfation of selected mono-hydroxyflavones by sulfotransferases in vitro: a species and gender comparison.

Authors:  Cai Hua Yang; Lan Tang; Chang Lv; Ling Ye; Bi Jun Xia; Ming Hu; Zhong Qiu Liu
Journal:  J Pharm Pharmacol       Date:  2011-07       Impact factor: 3.765

2.  Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae.

Authors:  Chenrui Li; Li Zhang; Limin Zhou; Siu Kwan Wo; Ge Lin; Zhong Zuo
Journal:  AAPS J       Date:  2011-12-14       Impact factor: 4.009

Review 3.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

Review 4.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

5.  Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1.

Authors:  Baojian Wu; Shuxing Zhang; Ming Hu
Journal:  Mol Pharm       Date:  2011-10-21       Impact factor: 4.939

6.  Hepatoenteric recycling is a new disposition mechanism for orally administered phenolic drugs and phytochemicals in rats.

Authors:  Yifan Tu; Lu Wang; Yi Rong; Vincent Tam; Taijun Yin; Song Gao; Rashim Singh; Ming Hu
Journal:  Elife       Date:  2021-07-01       Impact factor: 8.140

7.  Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by wogonin.

Authors:  Gao Chengcheng; Xie Rui; Ma Tianheng; Yan Wei; Pang Liqun
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

8.  Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles.

Authors:  Yong Ma; Song Gao; Ming Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-07-19       Impact factor: 3.205

9.  Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cells.

Authors:  Yingjie Wei; Baojian Wu; Wen Jiang; Taijun Yin; Xiaobin Jia; Sumit Basu; Guangyi Yang; Ming Hu
Journal:  Mol Pharm       Date:  2013-04-23       Impact factor: 4.939

10.  Regioselective glucuronidation of andrographolide and its major derivatives: metabolite identification, isozyme contribution, and species differences.

Authors:  Xiangge Tian; Sicheng Liang; Chao Wang; Baojian Wu; Guangbo Ge; Sa Deng; Kexin Liu; Ling Yang; Xiaochi Ma
Journal:  AAPS J       Date:  2014-09-10       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.